Drug Profile
Research programme: ABC-transporter modulators - Immungenetics
Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Immungenetics
- Class Antidementias; Antiparkinsonians; Small molecules
- Mechanism of Action ATP-binding cassette transporter modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Huntington's disease; Lewy body disease; Parkinson's disease
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for preclinical development in Huntington's-disease in Germany
- 28 Mar 2022 No recent reports of development identified for preclinical development in Lewy body disease in Germany
- 28 Mar 2022 No recent reports of development identified for preclinical development in Parkinson's-disease in Germany